BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

SIRT5 overexpression could rescue mitochondrial disease induced by SUCLA2 mutations

By Claire Quang, Staff Writer
December 31, 2020 5:24 PM UTC

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Mitochondrial disease...

BCIQ Company Profiles

Buck Institute for Research on Aging

Gladstone Institutes

University of California San Francisco

University of Helsinki

BCIQ Target Profiles

Sirtuin 5 (SIRT5)

Succinate-CoA ligase ADP-forming beta subunit (SUCLA2)

BCIQ Company Profiles

Buck Institute for Research on Aging

Gladstone Institutes

University of California San Francisco

University of Helsinki

BCIQ Target Profiles

Sirtuin 5 (SIRT5)

Succinate-CoA ligase ADP-forming beta subunit (SUCLA2)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS